Clinical Trial Update: A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial updates adherence to a once-monthly ibandronate regimen (Bonviva) in women with postmenopausal osteoporosis, with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Bonviva (ibandronic acid)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Postmenopausal Osteoporosis | Phase 4 | Status: COMPLETED | Results posted: 2016-10-24